Fas is expressed in murine pancreatic islet cells and an insulinoma cell line but does not mediate their apoptosis in vitro

Autoimmunity

Volumn 29, Issue 3, 1999, Pages 189-199

  Lee, Myung Shik ^a   Kim, Sunshin ^a   Chung, Jae Hoon ^a   Lee, Moon Kyu ^a   Kim, Kwang Won ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Apoptosis; Fas; Pancreatic cell

Indexed keywords

CYCLOHEXIMIDE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; FEMALE; FLOW CYTOMETRY; MOUSE; NONHUMAN; PANCREAS ISLET CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TUMOR CELL LINE;

EID: 0032963384     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908998534     Document Type: Article

References (40)

1. Christianson, S.W., Shultz, L.D. and Leiter, E.H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Diabetes 1993; 42: 44-55.
2. Haskins, K. and McDuffie, M. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990; 249: 1433-6.
3. Bradley, B.J., Haskins, K., La Rosa, F.G. and Lafferty, K.L. CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes 1992; 41: 1603-8.
4. Wang, B., Gonzalez, A., Benoist, C. and Mathis, D. The role of CD8+ cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 1996; 26: 1762-9.
5. Signore, A., Cooke, A., Pozzilli, P., Butcher, G., Simpson, E. and Beverley, P.C. Class II and IL-2 receptor positive cells in the pancreas of NOD mice. Diabetologia 1987; 30: 902-5.
6. Hanafusa, T., Fuhino-Kunihara, H., Miyazaki, A., Yamada, K., Nakajima, H., Miyagawa, J., Kono, K. and Tarui, S. Expression of class II MHC antigens on pancreatic β cells in the NOD mouse. Diabetologia 1987; 30: 104-8.
7. Wang, Y., Pontesilli, O., Gill, R.D., La Rosa, F.G. and Lafferty, K.J. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA 1991; 88: 527-31.
8. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H. and Golstein, P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528-30.
9. Mogil, R.J., Radvanyi, L., Gonzalez-Quintial, R., Miller, R., Mills, G., Theofilopoulos, A.N. and Green, D.R. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 1995; 7: 1451-8.
10. Parijs, L.V., Ibraghimov, A. and Abbas, A.K. The role of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 1996; 4: 321-8.
11. Ju, S.-T., Cui, H., Panka, D.J., Ettinger, R. and A. M.-R., Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA 1994; 91: 4185-9.
12. Stalder, T., Hahn, S. and Erb, P. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J. Immunol. 1994; 152: 1127-33.
13. Wang, R., Rogers, A.M., Ratliff, T.L. and Russell, J.H. CD95-dependent bystander lysis caused by CD4+ T helper 1 effectors. J. Immunol. 1996; 157: 2961-8.
14. Zamvil, S.S., Nelson, P.A., Mitchell, D.J., Knobler, R.L., Fritz, R.B. and Steinman,. L. Encephalitogenic T cell clones specific for myelin basic protein. An usual bias in antigen recognition. J. Exp. Med. 1985; 162: 2107-24.
15. Zamvil, S., Nelson, P., Protter, J., Mitchell, D., Knobler, R., Fritz, R. and Steinman, L. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 1985; 317: 355-8.
16. Dowling, P., Shang, G., Raval, S., Menonna, J., Cook, S. and Husar, W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple scleosis brain. J. Exp. Med. 1996; 184: 1513-8.
17. Chervonsky, A.V., Wang, Y., Wong, F.S., Visintin, I., Flavell, R.A., Janeway, C.A. and Matis, L.A. The role of Fas in autoimmune diabetes. Cell 1997; 89: 17-24.
18. Itoh, N., Imagawa, A., Hanafusa, T., Waguri, M., Yamamoto, K., Iwahashi, H., Moriwaki, M., Nakajima, H., Miyagawa, J., Namba, M., Makino, S., Nagata, S., Kono, M. and Matsuzawa, Y. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 1997; 186: 613-8.
19. Yagi, N., Yokono, K., Amano, K., Nagata, M., Tsukamoto, K., Hasegawa, Y., Yoneda, R., Okamoto, N., Moriyama, H., Miki, M., Tominaga, Y., Miyazaki, J.-i., Yagita, H., Okumura, K., Mizoguchi, A., Miki, A., Ide, C., Maeda, S. and Kasuga, M. Expression of intercellular adhesion molecule 1 on pancreatic β-cells accelerates β-cell destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes 1995; 44: 744-52.
20. Matsumoto, K., Fukunaga, K., Miyazaki, J.-i., Shichiri, M. and Miyamoto, E. Ca2+/calmodulin-dependent protein kinase 11 and synasin I-like protein in mouse insulinoma MIN6 cells. Endocrinology 1995; 136: 3784-93.
21. Kayagaki, N., Yamaguchi, N., Nagao, F., Matsuo, S., Maeda, H., Okumura, K. and Yagita, H. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 1997; 94: 3914-9.
22. Lee, M.-S., Wogensen, L., Shizuru, J., Oldstone, M.B.A. and Sarvetnick, N. Pancreatic islet production of murine interleukin 10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 1994; 93: 1332-8.
23. Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R. and Ferguson, T.A. Fas ligand-induced apoptosis as a mechanism of immune previlege. Science 1995; 270: 1189-92.
24. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A. and Duke, R.C. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630-2.
25. Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R. and Galluzzo, A. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960-3.
26. Ogasawara, J., Suda, T. and Nagata, S. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J. Exp. Med. 1995; 181: 485-91.
27. Ni, R., Tomita, Y., Ichihara, A., Ishimura, K., Ogasawara, J. and Nagata, S. Fas-mediated apoptosis in primary cultured mouse hepatocyte. Exp. Cell Res. 1994; 215: 332-7.
28. Elstein, K.H. and Zucker, R.M. Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptoticsubpopulation. Exp. Cell. Res. 1994; 211: 322-31.
29. Santamaria, P., Utsugi, T., Park, B.-J., Averill, N., Kawazu, S. and Yoon, J.-W. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor α-chain CDR3 sequences. J. Immunol. 1995; 154: 2494-503.
30. Alderson, M.R., Tough, T.W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K.A., Goodwin, R.G., Smith, C.A., Ramsdell, F. and Lynch, D.H. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995; 181: 71-7.
31. Yang, Y., Mercep, M., Ware, C.F. and Ashwell, J.D. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoid. J. of Exp. Med. 1995; 181: 1673-82.
32. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. and Nagata, S. Expression of Fas ligand in cells of T cell lineage. J Immunol. 1995; 154: 3806-13.
33. Watanabe-Fukunaga, R., Brynnan, C.I., Itoh, N., Yonehara, S., Copeland, N.G., Jenkins, N.A. and Nagata, S. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J. Immunol. 1992; 148: 1274-9.
34. Yamada, K., Takane-Gyotoku, N., Yuan, X., Ichikawa, F. and Nonaka, K. Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 1996; 39: 1306-12.
35. Shima, Y., Nishimoto, N., Ogata, A., Fujii, Y., Yoshizaki, K. and Kishimoto, T. Myeloma cells express Fas antigen, APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood 1995; 85: 757-64.
36. Itoh, N., Tsujimoto, Y. and Nagata, S. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 1993; 151: 621-7.
37. Boise, L.H. and Thompson, C.B. Hierachial control of lymphocyte survival. Science 1996; 274: 67-8.
38. O'Brien, B.A., Harmon, B.V., Cameron, D.P. and Allan, D.J. Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 1997; 46: 750-7.
39. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T. and Nagata, S. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806-9.
40. Biancone, L., De Martino, A., Orlandi, V., Conaldi, P.G., Toniolo, A. and Camussi, G. Development of inflammatory angiogenesis by local stimulation with Fas in vivo. J. Exp. Med. 1997; 186: 147-52.